Skip to main content
ICPE 2023 Main banner
Final Program


ICPE 2023 Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Daniel C. Beachler, PhD, MHS (he/him/his)

Sr. Director, Safety & Epidemiology
Carelon Research
Wilmington, United States

As the Sr. Director of the Safety and Epidemiology team at Carelon Research, Dr. Beachler oversees the execution of pharmacoepidemiology, risk management, and medical product safety studies for a portfolio of industry, academic, and government clients. Dr. Beachler has experience conducting validation studies and utilizing predictive modeling and machine learning methods to develop claims-based algorithms to improve cohort and outcome classification. He has scientific oversight of drug safety studies including post authorization safety studies (PASS), Risk Evaluation and Mitigation Strategy (REMS), post-market requirement (PMR) studies. Prior to joining Carelon Research, Dr. Beachler was a Cancer Prevention Fellow at the National Cancer Institute, Division of Cancer Epidemiology and Genetics. He holds a MHS and PhD in Epidemiology from Johns Hopkins School of Public Health and a BS in Bioengineering from The Pennsylvania State University. Dr. Beachler has published dozens of manuscripts in the peer-reviewed medical literature. He has presented his work at scientific meetings and to regulatory authorities worldwide.

Disclosure information not submitted.

Presentation(s):

Email Daniel